Articles and Editorials|

Reformulating digital health: From hope to hype to health

June 2020 News

In the June issue of ONdrug Delivery magazine, SHL’s Chelsea Williams, Ramin Rafiei, and Ralph Howald share our roadmap and associated technology investments towards digital healthcare transformation.

Over the past three decades, SHL Medical has set the foundation for the decentralization of drug administration across a wide spectrum of chronic diseases and conditions. These complex treatments have graduated from a sole focus on safety and efficacy to acknowledging the importance of patient convenience and adherence. At present, innovation in drug delivery is maturing into connected therapeutics, which allows patients to self-manage their complex conditions as part of their integrated care plans – pairing healthcare with technology.

“As we transform our patient-centric drug delivery devices to life-centric therapeutic solutions, we emphasize a focus on the whole patient journey” Williams, lead author of the article, explains.

“Our passion fuels our meticulous work to ensure that our products are usable, useful, and can be utilized across the healthcare industry. These elements are central to digital health success.” Williams adds.

To learn more about SHL’s digital healthcare innovations and initiatives, download the full article here, or read it online at ONdrugDelivery (log in required).

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News